Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo)
Condition: Ebola Virus Disease Intervention: Drug: Ad26.ZEBOV/MVA-BN-Filo Sponsors: MRC/UVRI Uganda Research Unit on Aids; Epicentre, Paris, France and Mbarara, Uganda; Janssen Pharmaceutica N.V., Belgium; Coalition for Epidemic Preparedness Innovations Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials
Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP)
Conditions: HIV/AIDS; HIV Infections; Sexually Transmitted Diseases; Vaccination; Adherence, Medication; Side Effect of Drug; Preexposure Prophylaxis Interventions: Behavioral: Harm reduction of informal PrEP use; Other: PrEP follow up based on point of care testing Sponsors: BCN Checkpoint; Projecte dels NOMS-Hispanosida (BCN Checkpoint and BCN PrEP·Point); Fundacio Lluita Contra la SIDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2019 Category: Research Source Type: clinical trials